Caredx joins forces with the national foundation for transplants to improve post-transplant medication adherence

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it is joining forces with the national foundation for transplants (nft) in offering its transplant pharmacy services to nft patient members to help them manage the complexity of post-transplant medication adherence. medicatio.
CDNA Ratings Summary
CDNA Quant Ranking